ACTUAL OTEZLA PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS, IMPROVEMENT FROM BASELINE4*
Week 0
Week 16
75% reduction in PASI score†
Week 32
Patient’s week 16
PASI-75 result remained
stable up to week 32
Week 0
Week 16
77% reduction in PASI score†
Week 32
Patient’s week 16
PASI-75 result remained
stable up to week 32
Week 0
Week 16
85% reduction in PASI score‡
Week 32
Data not available
What results with OTEZLA have your patients with moderate-to-severe PsO
seen?
* Actual patients. Individual results may vary.
† Actual patient from Celgene Photo Library.
‡ Actual patient from ESTEEM clinical trial.